Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Intelgenx Corp patents

Recent patent applications related to Intelgenx Corp. Intelgenx Corp is listed as an Agent/Assignee. Note: Intelgenx Corp may have other listings under different names/spellings. We're not affiliated with Intelgenx Corp, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "I" | Intelgenx Corp-related inventors

Method of treatment and device for the improved bioavailability of leukotriene receptor antagonists

Disclosed is a method of administration and device for the improved bioavailability of leukotriene receptor antagonists. This method and device involve an alkaline surface ph oral film dosage form designed to deliver leukotriene receptor antagonists, such as montelukast, to the stomach in an amorphous precipitate suspended in aqueous medium. ... Intelgenx Corp

Device and method of treating conditions associated with neuroinflammation

Disclosed is a device and method for treating a neurodegenerative disease or condition associated with neuroinflammation induced by a leukotriene. The device is a film unit dosage form having a film layer and a safe and effective amount of a leukotriene receptor antagonist or leukotriene synthesis inhibitor. ... Intelgenx Corp

Solid oral film dosage forms and methods for making same

Improved pharmaceutical solid oral dosage forms for the buccal and/or sublingual delivery of tadalafil. The improved delivery systems for solubilizing and stabilizing pharmaceutically active ingredients exhibit enhanced methods of preparation by the use improved solubilization systems which can maintain the tadalafil in a buccal and/or sublingual oral dosage form or a polymeric film matrix that provides improved bioavailability and/or absorption of tadalafil.. ... Intelgenx Corp

Montelukast transmucosal film

An oral film product in which a pharmaceutically active agent is stabilized in its partially-ionized form to better facilitate oral transmucosal delivery is provided. The film includes a bioadhesive layer including a pharmaceutically active agent having a logarithmic acid dissociation constant that is less than 4.5 and which is complexed with a cationic polymer.. ... Intelgenx Corp

Film dosage form with extended release mucoadhesive particles

An orally administered dosage form that facilitates delivery of an agent locally in the buccal cavity for a sustained period of time includes mucoadhesive particles that are made of at least a mucoadhesive material combined with the agent, and which are dispersed in a disintegrating film. The dosage form is capable of delivering an agent to a patient at the desired oral mucosa site over an extended period of time while reducing patient discomfort or annoyance associated with conventional sustained release mucoadhesive films that must reside on the oral mucosa during the period of sustained release.. ... Intelgenx Corp

Loxapine film oral dosage form

A loxapine film oral dosage form includes loxapine salt, free base, or prodrug in an amount effective to provide relief from acute agitation associated with schizophrenia or bipolar 1 disorder via oral transmucosal delivery, dispersed in a polymeric film forming system. Advantageously, the film oral dosage form further includes a sweetener, a refreshing agent, an antioxidant, a ph stabilizer, a penetration enhancer, a mucoadhesive agent and a plasticizer. ... Intelgenx Corp

Solid oral film dosage forms and methods for making same

Oral film dosage forms that provide improved solubilization and stabilization of an active ingredient in particle form include at least one primary crystallization inhibitor in an amount that inhibits growth and/or agglomeration of the active ingredient, a polyoxyethylated fatty acid glycerides in an amount that further enhances inhibition of crystallization, growth and agglomeration of the particles of the pharmaceutically active ingredient; and at least one plasticizer present in an amount that is effective to increase flexibility and elasticity of the film dosage form.. . ... Intelgenx Corp

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Intelgenx Corp in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Intelgenx Corp with additional patents listed. Browse our Agent directory for other possible listings. Page by